Healios K.K.

2026/08/21 Updated
Market Cap: $244.6M (¥38.9B)
Stock Price: $1.81 (¥288)
Exchange Rate: 1 USD = ¥158.98

Announcement on the finalization of the issuance content for Issued Stock Options (29th Stock Acquisition Rights)

Issuance contents for stock options have been finalized. Recipients: 52 people; total issued: 121,356 units; shares subject to exercise: common shares 12,135,600.

Importance:
Page Updated: July 2, 2026
IR Disclosure Date: July 2, 2026

Key Figures

  • Total number of stock options: 121,356
  • Type of shares: Common shares
  • Number of shares subject to exercise: 12,135,600 shares
  • Number of recipients: 52 people

AI要約

Section Heading

This notice announces that, based on the resolution of the Board of Directors meeting held on June 17, 2026, the previously undecided issuance contents for the stock options have been finalized. The recipients consist of directors, executive officers, employees, and directors/employees of subsidiaries, totaling 52 individuals. The total allocation is 121,356 units, and the shares subject to exercise are 12,135,600 common shares.

Section 2 Heading

This matter is being implemented as part of the capital policy and remuneration system, and details such as specific exercise conditions and exercise periods will be disclosed separately. The future schedule and market impact are currently unknown, and investors should monitor progress of exercise and potential dilution effects.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Human Therapeutics Corporation

Company overview · Stock price · Financial data · All IR

View company page →